BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4833376)

  • 1. Studies on lankacidin-group (T-2636) antibiotics. V. Chemical structures of lankacidin-group antibiotics. 1.
    Harada S; Kishi T
    Chem Pharm Bull (Tokyo); 1974 Jan; 22(1):99-108. PubMed ID: 4833376
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on lankacidin-group (T-2636) antibiotics. VI. Chemical structures of lankacidin-group antibiotics. II.
    Harada S
    Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2201-10. PubMed ID: 1212749
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on lankacidin-group (T-2636) antibiotics. VII. Structure-activity relationships of lankacidin-group antibiotics.
    Harada S; Yamazaki T; Hatano K; Tsuchiya K; Kishi T
    J Antibiot (Tokyo); 1973 Nov; 26(11):647-57. PubMed ID: 4792112
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on lankacidin-group (T-2636) antibiotics. X. Microbial conversion of lankacidin-group antibiotics.
    Nakahama K; Harada S; Igarasi S
    J Antibiot (Tokyo); 1975 May; 28(5):390-4. PubMed ID: 240790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side chain modifications in lankacidin group antibiotics.
    McFarland JW; Pirie DK; Retsema JA; English AR
    Antimicrob Agents Chemother; 1984 Feb; 25(2):226-33. PubMed ID: 6370129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on lankacidin-group (T-2636) ANTIBIOTICS. IX Preparation of C-labeled lankacidin C 14-propionate.
    Hatano K; Harada S; Kishi T
    J Antibiot (Tokyo); 1975 Jan; 28(1):15-20. PubMed ID: 1126865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on lankacidin-group (T-2636) antibiotics. 8. Metabolism of lankacidin C 14-propionate in rats and mice.
    Harada S; Tanayama S; Kishi T
    J Antibiot (Tokyo); 1973 Nov; 26(11):658-68. PubMed ID: 4792113
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on antibiotic SF-837, a new antibiotic. IV. Structures of antibiotics SF-837 A 2 , A 3 and A 4 .
    Tsuruoka T; Inouye S; Shomura T; Ezaki N; Niida T
    J Antibiot (Tokyo); 1971 Aug; 24(8):526-36. PubMed ID: 5092787
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships.
    Oostu K; Matsumoto T; Harada S; Kishi T
    Cancer Chemother Rep; 1975; 59(5):919-28. PubMed ID: 1148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structures of Bundlin A (lankacidin) and Bundlin B.
    Uramoto M; Otake N; Ogawa Y; Yonehara H
    Tetrahedron Lett; 1969 Jun; (27):2249-54. PubMed ID: 5796585
    [No Abstract]   [Full Text] [Related]  

  • 11. [New antibiotics, juglomycin. 2. Structure of juglomycin A and B].
    Tanaka N; Ogata H; Ushiyama K; Ono H
    Jpn J Antibiot; 1971 Oct; 24(5):222-4. PubMed ID: 5316819
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereochemical problems in macrolide antibiotics.
    Celmer WD
    Pure Appl Chem; 1971; 28(4):413-53. PubMed ID: 4947320
    [No Abstract]   [Full Text] [Related]  

  • 13. [STUDY OF THE CHEMICAL PROPERTIES OF OLIVOMYCIN].
    GRINEV AN; KOZLOVA LA; MEZENTSEV AS
    Antibiotiki; 1964 Feb; 9():138-40. PubMed ID: 14186709
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor Activity of Lankacidin Group Antibiotics Is Due to Microtubule Stabilization via a Paclitaxel-like Mechanism.
    Ayoub AT; Abou El-Magd RM; Xiao J; Lewis CW; Tilli TM; Arakawa K; Nindita Y; Chan G; Sun L; Glover M; Klobukowski M; Tuszynski J
    J Med Chem; 2016 Oct; 59(20):9532-9540. PubMed ID: 27718573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [STUDY OF OLIVOMYCIN HOMOGENEITY].
    BRAZHNIKOVA MG; KRUGLIAK EB; BORISOVA VN; FEDOROVA GB
    Antibiotiki; 1964 Feb; 9():141-6. PubMed ID: 14186710
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycinamicins, new macrolide antibiotics. IV. Structure of mycinamicin III.
    Hayashi M; Ohno M; Katsumata S; Satoi S; Harada K; Takeda M; Suzuki M
    J Antibiot (Tokyo); 1981 Mar; 34(3):276-81. PubMed ID: 7275809
    [No Abstract]   [Full Text] [Related]  

  • 17. STRUCTURE OF STREPTOLYDIGIN.
    RINEHART KL; BECK JR; BORDERS DB; EPSTEIN WW; KINSTLE TH; SPICER LD; KRAUSS D; BUTTON AC
    Antimicrob Agents Chemother (Bethesda); 1963; 161():346-8. PubMed ID: 14274922
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Syntheses of macrolide antibiotics. II. Methylmycin.
    Masamune S; Yamamoto H; Kamata S; Fukuzawa A
    J Am Chem Soc; 1975 Jun; 97(12):3513-5. PubMed ID: 237956
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of modular-iterative mixed biosynthesis of lankacidin by heterologous expression and gene fusion.
    Tatsuno S; Arakawa K; Kinashi H
    J Antibiot (Tokyo); 2007 Nov; 60(11):700-8. PubMed ID: 18057700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemical studies on antibiotics aminosidin. I. Separation of aminosidin I and II, and relation to paromomycin I and II].
    Taniyama H; Sawada Y; Hashimoto K; Chung YH; Kitagawa T
    Yakugaku Zasshi; 1971 Dec; 91(12):13562-6. PubMed ID: 5169222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.